HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell.

Abstract
Medullary thyroid carcinoma in both sporadic and familial forms is a curable disease if detected early and treated by the proper surgery. The advent of genetic screening for the RET protooncogene portends great promise in the earlier diagnosis and treatment of familial forms of MTC. New chemotherapy protocols have produced some tumor regression in patients with metastatic MTC. Improved use of Adriamycin and hyper-fractionated radiotherapy combined with debulking procedures has prolonged survival in anaplastic thyroid cancer. Thyroid gland lymphoma, if diagnosed early and treated by combined chemoradiotherapy, carries a good prognosis for survival. The best treatment for thyroid sarcomas and SCC of the thyroid is early diagnosis and aggressive surgery combined with radiotherapy.
AuthorsJ R Austin, A K el-Naggar, H Goepfert
JournalOtolaryngologic clinics of North America (Otolaryngol Clin North Am) Vol. 29 Issue 4 Pg. 611-27 (Aug 1996) ISSN: 0030-6665 [Print] United States
PMID8844733 (Publication Type: Journal Article, Review)
Chemical References
  • Antibiotics, Antineoplastic
  • Doxorubicin
Topics
  • Antibiotics, Antineoplastic (therapeutic use)
  • Carcinoma (diagnosis, surgery)
  • Carcinoma, Medullary (diagnosis, genetics, secondary, surgery)
  • Carcinoma, Squamous Cell (diagnosis, surgery)
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Doxorubicin (therapeutic use)
  • Genetic Testing
  • Humans
  • Lymphoma (diagnosis, therapy)
  • Prognosis
  • Proto-Oncogenes (genetics)
  • Radiotherapy, Adjuvant
  • Sarcoma (diagnosis, surgery)
  • Survival Rate
  • Thyroid Neoplasms (diagnosis, genetics, surgery)
  • Thyroidectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: